leisure time -WSS

leisure time

author：fashion 2025-09-03 09:37:14 - browse：71583

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： With FDA staff opposed to Sarepta therapy, top official intervened

WSS

Medicare reduced heart disease by changing how it pays doctors

Pharmacists can make shortage drugs, but at what cost?

First Opinion Podcast: Long Covid needs a new approach

Pharmacists can make shortage drugs, but at what cost?

What would happen to your eyes if you looked at the solar eclipse?

STAT Summit: Biotech founders on deal

entertainment

leisure time

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Weight bias in eating disorder treatment complicated by new weight loss drugs

New air purifier tech could be key to improving indoor air quality

Cloning humans is technically possible. It's curious no one has tried

Dobbs anniversary: the lost opportunity of abortion as health care

With FDA staff opposed to Sarepta therapy, top official intervened

Tori Bowie and the unacceptable rates of Black maternal death

Hospital price transparency does save money, advocate argues

After affirmative action ruling, medical educators look to 'holistic review'

How climate

entertainment

Researchers explore possible ties between long Covid, menopause

FDA gives detailed accounting of AI

UnitedHealth’s board chair also owns a personal investment firm

STAT's guide to the next generation of CAR

With FDA staff opposed to Sarepta therapy, top official intervened

FDA gives detailed accounting of AI

entertainment

explore

hotspot

focus